Pharmacokinetics of daily versus monthly vitamin D3 supplementation in non-lactating women

被引:23
|
作者
Meekins, M. E. [1 ]
Oberhelman, S. S. [2 ]
Lee, B. R. [1 ]
Gardner, B. M.
Cha, S. S. [3 ]
Singh, R. J. [4 ]
Pettifor, J. M. [5 ]
Fischer, P. R. [6 ]
Thacher, T. D. [2 ]
机构
[1] Mayo Clin Hlth Syst, Dept Pharm, Mankato, MN 56001 USA
[2] Mayo Clin, Dept Family Med, Rochester, MN USA
[3] Mayo Clin, Dept Biostat & Informat, Rochester, MN USA
[4] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA
[5] Univ Witwatersrand, Dept Paediat, Dev Pathways Hlth Res Unit, Johannesburg, South Africa
[6] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN USA
关键词
women; Metabolism; vitamin D; pharmacokinetics; LACTATION;
D O I
10.1038/ejcn.2013.278
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
This study compared serum cholecalciferol and 25-hydroxyvitamin D (25(OH)D) concentrations over four weeks in healthy, nob-pregnant, non-lactating females aged 18-40 years, Who were randomized to oral cholecalciferol 5000 international units (IU) daily for 28 days or a single dose of 150 000IU. The study was conducted in Rochester, MN in March and April of 2010. We found no difference in mean 25(OH)D between treatment groups on study day 0 or day 28 (P=0.14 and 0.28, respectively). The daily group had 11 more days of detectable serum cholecalciferol than the single-dose group (P<0.001). There was no difference observed in cholecalciferol area under the curve (AUC(28)) between groups (P=0.49). However, the single-dose group had a significantly greater mean 25(OH)D AUC(28) compared with the daily group (P<0.001).
引用
收藏
页码:632 / 634
页数:3
相关论文
共 50 条
  • [31] Vitamin D3 supplementation: Response and predictors of vitamin D3 metabolites - A randomized controlled trial
    Lehmann, Ulrike
    Riedel, Annett
    Hirche, Frank
    Brandsch, Corinna
    Girndt, Matthias
    Ulrich, Christof
    Seibert, Eric
    Henning, Christian
    Glomb, Marcus A.
    Dierkes, Jutta
    Stangl, Gabriele I.
    CLINICAL NUTRITION, 2016, 35 (02) : 351 - 358
  • [32] Vitamin D3 increases in abdominal subcutaneous fat tissue after supplementation with vitamin D3
    Didriksen, Allan
    Burild, Anders
    Jakobsen, Jette
    Fuskevag, Ole Martin
    Jorde, Rolf
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 172 (03) : 235 - 241
  • [33] Vitamin D activity of breast milk in women randomly assigned to vitamin D3 supplementation during pregnancy
    Wall, Clare R.
    Stewart, Alistair W.
    Camargo, Carlos A., Jr.
    Scragg, Robert
    Mitchell, Edwin A.
    Ekeroma, Alec
    Crane, Julian
    Milne, Tania
    Rowden, Judy
    Horst, Ronald
    Grant, Cameron C.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2016, 103 (02): : 382 - 388
  • [35] Daily vs. monthly oral vitamin D3 for treatment of symptomatic vitamin D deficiency in infants: a randomized controlled trial
    Gora, Anupriya
    Singh, Preeti
    Debnath, Ekta
    Malhotra, Rajeev Kumar
    Seth, Anju
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2023, 36 (07): : 683 - 691
  • [36] Vitamin D3 at the 1500 IU/day dose comparing daily, weekly, or monthly administration to elderly
    Ish-Shalom, S
    Vieth, R
    Salganik, T
    Segal, E
    Raz, B
    Bromberg, I
    BONE, 2005, 36 : S159 - S159
  • [37] Safety And Efficacy of Daily High Dose Vitamin D3 Supplementation in Sickle Cell Disease
    Dougherty, Kelly A.
    Bertolaso, Chiara
    Schall, Joan I.
    Smith-Whitley, Kim
    Stallings, Virginia A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2015, 47 (05): : 804 - 804
  • [38] Tissue content of vitamin D3 and 25-hydroxy vitamin D3 in minipigs after cutaneous synthesis, supplementation and deprivation of vitamin D3
    Burild, Anders
    Frandsen, Henrik Lauritz
    Poulsen, Morten
    Jakobsen, Jette
    STEROIDS, 2015, 98 : 72 - 79
  • [39] Vitamin D and Vitamin D3 Supplementation during Photodynamic Therapy: A Review
    Mazur, Anna
    Koziorowska, Katarzyna
    Dynarowicz, Klaudia
    Aebisher, David
    Bartusik-Aebisher, Dorota
    NUTRIENTS, 2022, 14 (18)
  • [40] Vitamin D3 supplementation, musculoskeletal (MS) symptoms and aromatase inhibitor (Al) pharmacokinetics from the vitamin D3AI study
    Shapiro, A. C.
    Kirstein, M. N.
    Robien, K.
    Swenson, K. K.
    Nissen, M. J.
    Menk, J. S.
    Adlis, S.
    Tsai, M.
    Lerner, R.
    Strayer, L.
    Zwicky, K.
    CANCER RESEARCH, 2013, 73